SA/HA double-network hydrogel combined with PVDF electret membrane enhances osteogenic differentiation of DPSCs and promotes mandibular bone defect repair
Zheng K., Xiao J., Qian J., Feng G., Zhang X., Huang D.
Laboratory Study, published in Regen Ther (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Regen Ther (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42059007
- PMCID
- PMC13123325
- DOI
- 10.1016/j.reth.2026.101118
Abstract (original English)
Introduction Bone tissue defects frequently occur following trauma, bone tumor resection, and orthopedic surgery. The complex local microenvironment serves as a critical factor impeding bone tissue repair. Cell-based scaffolds typically exhibit stable physicochemical properties, provide a favorable growth microenvironment. Hydrogels and electret membranes have been widely applied in bone tissue engineering. Methods In this study, we fabricated polyvinylidene fluoride (PVDF) electret membranes and sodium alginate/sodium hyaluronate (SA/HA) double-network hydrogels separately, and systematically characterized their physicochemical and biological properties. Results Following verification of their favorable biocompatibility, we found that the combined application of SA/HA@PVDF composites significantly enhances calcium nodule formation in human dental pulp stem cells (DPSCs) in vitro. In addition, the expression levels of osteogenic marker proteins were elevated in the SA/HA@PVDF group and were significantly higher than those in the single-agent application groups, indicating that SA/HA@PVDF exhibits a stronger capacity to promote the osteogenic differentiation of DPSCs in vitro. Subsequently, rat mandibular defect models were established, and PVDF electret membranes, SA/HA hydrogels, and SA/HA@PVDF composites were transplanted into the defect sites. The results of micro-computed t
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.